Shares of Vertex Pharmaceuticals Inc.
VRTX,
rose 1.33% to $222.53 Monday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index
SPX,
rising 0.64% to 4,796.56 and the Dow Jones Industrial Average
DJIA,
rising 0.68% to 36,585.06. The stock’s rise snapped a two-day losing streak. Vertex Pharmaceuticals Inc. closed $20.46 short of its 52-week high ($242.99), which the company reached on January 25th.
The stock outperformed some of its competitors Monday, as Johnson & Johnson
JNJ,
rose 0.27% to $171.54, Merck & Co. Inc.
MRK,
rose 0.30% to $76.87, and AbbVie Inc.
ABBV,
rose 0.01% to $135.42. Trading volume (1.4 M) remained 547,155 below its 50-day average volume of 1.9 M.
Editor’s Note: This story was auto-generated by Automated Insights, an automation technology provider, using data from Dow Jones and FactSet. See our market data terms of use.
Read More: Vertex Pharmaceuticals Inc. stock rises Monday, outperforms market